¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"REC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • rectouterine fold
    Á÷ÀåÀÚ±ÃÁÖ¸§, °ðâÀÚÀÚ±ÃÁÖ¸§
  • rectovaginal
    Á÷ÀåÁú-, °ðâÀÚÁú-
  • rectovaginal fistula
    Á÷ÀåÁú·ç, °ðâÀÚÁú»û±æ
  • rectovaginal septum
    °ðâÀÚÁú»çÀ̸·, Á÷ÀåÁúÁß°Ý
  • rectovaginoabdominal
    Á÷ÀåÁúº¹ºÎ-, °ðâÀÚÁú¹èºÎ-
  • rectovesical
    Á÷À广±¤-, °ðâÀڹ汤-
  • rectovesical excavation
    Á÷À广±¤¿À¸ñ, °ðâÀڹ汤¿À¸ñ
  • rectovesical fold
    Á÷À广±¤ÁÖ¸§, °ðâÀڹ汤ÁÖ¸§
  • rectovesical muscle
    °ðâÀڹ汤±Ù, Á÷À广±¤±Ù
  • rectovesical pouch
    Á÷À广±¤¿À¸ñ, °ðâÀڹ汤¿À¸ñ
  • rectovesical septum
    Á÷À广±¤Áß°Ý, °ðâÀڹ汤»çÀ̸·
  • rectovestibular fistula
    Á÷ÀåÀüÁ¤´©°ø, °ðâÀÚÁú¾î±Í»û±æ, Á÷ÀåÀüÁ¤·ç
  • rectum
    Á÷Àå, °ðâÀÚ
  • rectus
    °ðÀº-, Á÷-
  • rectus abdominis flap
    ¹è°ðÀº±ÙÆÇ, º¹Á÷±ÙÆÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • rectoperineorrhaphy
    °ðâÀÚ»ôºÀÇÕ¼ú, Á÷ÀåȸÀ½ºÀÇÕ¼ú
  • rectopexy
    °ðâÀÚ°íÁ¤¼ú, Á÷Àå°íÁ¤¼ú
  • rectorectostomy
    °ðâÀÚ°ðâÀÚ¿¬°á¼ú, Á÷ÀåÁ÷À忬°á¼ú
  • rectoromanoscope
    (¢¡proctosigmoidoscope) °ðâÀÚ±¸ºÒâÀÚº¸°³, Á÷Àå¿¡½ºÀÚ°áÀå°æ
  • rectoromanoscopy
    °ðâÀÚ±¸ºÒâÀÚº¸°³°Ë»ç¹ý, Á÷Àå¿¡½ºÀÚ°áÀå°æ°Ë»ç¹ý
  • rectorrhaphy
    °ðâÀÚºÀÇÕ¼ú, Á÷ÀåºÀÇÕ¼ú
  • rectoscope
    °ðâÀÚº¸°³, Á÷Àå°æ
  • rectoscopy
    °ðâÀÚº¸°³°Ë»ç¹ý, Á÷Àå°æ°Ë»ç¹ý
  • rectosigmoid
    °ðâÀÚ±¸ºÒâÀÚ-, °ðâÀÚÁÖ¸§Ã¢ÀÚ-
  • rectosigmoidectomy
    °ðâÀÚ±¸ºÒâÀÚÀýÁ¦¼ú, Á÷Àå¿¡½ºÀÚ°áÀåÀýÁ¦¼ú
  • rectosigmoidoscope
    (¢¡proctosigmoidoscope) °ðâÀÚ±¸ºÒâÀÚº¸°³, Á÷Àå¿¡½ºÀÚ°áÀå°æ
  • rectostenosis
    °ðâÀÚÇùÂøÁõ, Á÷ÀåÇùÂøÁõ
  • rectotome
    °ðâÀÚÀý°³Ä®, Á÷ÀåÀý°³µµ
  • rectotomy
    (¢¡proctotomy) °ðâÀÚÀý°³¼ú, Á÷ÀåÀý°³¼ú
  • rectourethral
    °ðâÀÚ¿äµµ-, Á÷Àå¿äµµ-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • reconstituted milk
    °¡°ø¿ìÀ¯(Ê¥ÍïéÚêá).
  • reconstruction
    À籸¼º(î¢Ï°à÷), Àç°Ç(î¢Ëï).
  • reconstruction algorithm
    À籸¼º ¿¬»ê
  • reconstruction/conjugation
    Àç°Ç
  • reconstructive operation
    Àç°Ç¼ö¼ú(î¢Ëï â¢âú).
  • reconstructive surgery
    Àç°Ç¿Ü°ú(î¢ËïèâΡ).
  • reconstructive surgery
    Àç°Ç¼ö¼ú, Àç°Ç¿Ü°ú
  • record
    ±â·Ï
  • record keeping
    ±â·Ï º¸°ü
  • record management
    ±â·Ï°ü¸®
  • recorder
    ±â·Ï±â
  • recording hygrometer
    ±â·Ï½Àµµ°è(ÑÀÒÓ ã¥öôͪ).
  • recording kata thermometer
    ±â·Ï īŸ¿Âµµ°è(Ë»ËÀÊÙËí̬˭).
  • recording mechanism
    ±â·Ï±â±¸(ÑÀÒÓѦÎý).
  • recovery
    ȸº¹
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • reciprocal system
    »ó¹Ý°è(ßÓÚãͧ).
  • reciprocal translocation
  • reciprocating supraventricular tachycardia
    Àç±Í¼º ½É½Ç»ó¼º ºó¸Æ.
  • reciprocity law
    »ó¹Ý¹ýÄ¢(ßÓÚãÛööÎ).
  • recirculating system
    Àç¼øÈ¯(¹æ)½Ä .
  • recirculation
    Àç¼øÈ¯
  • recirculation time
    Àç¼øÈ¯½Ã°£(î¢âàü»ãÁÊà).
  • reckoning test
    °¡»ê½ÃÇè(ʥߩãËúÐ).
  • reclaimed
    Àç»ý(î¢ßæ)µÈ.
  • reclaimed gypsum
    Àç»ý ¼®°í(î¢ßæà´ÍÇ).
  • reclaimed rubber
    Àç»ý°í¹«.
  • reclaiming process
    Àç»ý¹ý(ËøË×ËÑ).
  • reclotting phenomenon
    ÀçÀÀ°íÇö»ó(î¢ëêͳúÞßÚ).
  • recognition
    ÀÎÁö
  • recognition
    ÀνÄ(ìããÛ).
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
receptors, pancreatic hormone Cell surface proteins that bind pancreatic hormones with high affinity and trigger intracellular changes which influence the behaviour of cells. These include receptors for glucagon (secreted by alpha cells), insulin (secreted by beta cells), somatostatin (secreted by delta cells), and pancreatic peptide (secreted by pp cells). Some of these hormones and receptors also support neurotransmission.
(12 Dec 1998)
receptors, parathyroid hormone Cell surface proteins that bind parathyroid hormone with high affinity and trigger intracellular changes which influence the behaviour of cells. Parathyroid hormone receptors on bone, kidney, and gastrointestinal cells mediate the hormone's role in calcium and phosphate homeostasis.
(12 Dec 1998)
receptors, peptide Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behaviour of cells.
(12 Dec 1998)
receptors, phencyclidine Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for pcp. These are the pcp/sigma site, which binds both pcp and psychotomimetic opiates but not certain antipsychotics, and the pcp site, which selectively binds pcp analogs.
(12 Dec 1998)
receptors, pituitary hormone Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system.
(12 Dec 1998)
receptors, pituitary hormone-regulating hormone Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here.
(12 Dec 1998)
receptors, platelet-derived growth factor Specific molecular sites or structures on cell membranes that react with platelet-derived growth factor, its analogs, or antagonists, to elicit or to inhibit the specific response of the cell to this factor. Pdgf binds with different affinities and specificities to two structurally related receptors, the alpha-receptor and the beta-receptor. Both of these receptors are transmembrane proteins with an intracellular, ligand-stimulatable protein kinase domain.
(12 Dec 1998)
receptors, polymeric immunoglobulin Specialised fc receptors (receptors, fc) for polymeric immunoglobulins, which mediate transcytosis of polymeric IgA and IgM into external secretions. They are found on the surfaces of epithelial cells and hepatocytes. After binding to IgA, the receptor-ligand complex undergoes endocytosis, transport by vesicle, and secretion into the lumen by exocytosis. Before release, the part of the receptor (secretory component) that is bound to IgA is proteolytically cleaved from its transmembrane tail.
(12 Dec 1998)
receptors, presynaptic Neurotransmitter receptors located on or near presynaptic terminals or varicosities. Presynaptic receptors which bind transmitter molecules released by the terminal itself are termed autoreceptors.
(12 Dec 1998)
receptors, progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, a and b. Both are induced by oestrogen and have short half-lives.
(12 Dec 1998)
receptors, prolactin Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells' physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor.
(12 Dec 1998)
receptors, prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behaviour of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin d2 (dp receptors), prostaglandin e2 (ep1, ep2, and ep3 receptors), prostaglandin f2-alpha (fp receptors), and prostacyclin (ip receptors).
(12 Dec 1998)
receptors, prostaglandin e Cell surface receptors which bind prostaglandins with a high affinity and trigger intracellular changes which influence the behaviour of cells. Prostaglandin e receptors prefer prostaglandin e2 to other endogenous prostaglandins. They are subdivided into ep1, ep2, and ep3 types based on their effects and their pharmacology.
(12 Dec 1998)
receptors, purinergic Cell surface proteins that bind purines with high affinity and trigger intracellular changes which influence the behaviour of cells. The best characterised classes of purinergic receptors in mammals are the p1 receptors, which prefer adenosine, and the p2 receptors, which prefer ATP or ADP.
(12 Dec 1998)
receptors, purinergic p1 A class of cell surface receptors that prefers adenosine to other endogenous purines. Purinergic p1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (a1 and a2, or ri and ra). The methylxanthines, e.g., caffeine, bind to these receptors, but also have other unrelated effects.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 12
  • Receptor, Melatonin, MT1 - »õâ A melatonin receptor subtype that is primarily found in the HYPOTHALAMUS and in the KIDNEY.
    Synonyms : MT1 Receptor, Mel(1a)-Melatonin Receptor, MT1 Receptor, Melatonin, Receptor, MT1, Receptor, Melatonin MT1
  • Receptor, Melatonin, MT2 - »õâ A melatonin receptor subtype primarily found expressed in the BRAIN and RETINA.
    Synonyms : MT2 Receptor, Mel 1b Receptor, Melatonin 1b Receptor, MT2 Receptor, Melatonin, Receptor, MT2, Receptor, Melatonin 1b, Receptor, Melatonin MT2
  • Receptor, Muscarinic M1 - »õâ A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.
    Synonyms : Muscarinic Receptors M1, Receptors, Muscarinic M1, M1 Receptor, Muscarinic, M1 Receptors, Muscarinic, M1, Muscarinic Receptor, M1, Muscarinic Receptors, Muscarinic M1 Receptor, Muscarinic M1 Receptors, Receptor M1, Muscarinic, Receptors M1, Muscarinic
  • Receptor, Muscarinic M2 - »õâ A specific subtype of muscarinic receptor found in the lower BRAIN, the HEART and in SMOOTH MUSCLE-containing organs. Although present in smooth muscle the M2 muscarinic receptor appears not to be involved in contractile responses.
    Synonyms : Muscarinic Receptors M2, Receptors, Muscarinic M2, M2 Receptor, Muscarinic, M2 Receptors, Muscarinic, M2, Muscarinic Receptor, M2, Muscarinic Receptors, Muscarinic M2 Receptor, Muscarinic M2 Receptors, Receptor M2, Muscarinic, Receptors M2, Muscarinic
  • Receptor, Muscarinic M3 - »õâ A subclass of muscarinic receptor that mediates cholinergic-induced contraction in a variety of SMOOTH MUSCLES.
    Synonyms : Muscarinic Receptors M3, Receptors, Muscarinic M3, M3 Receptor, Muscarinic, M3 Receptors, Muscarinic, M3, Muscarinic Receptor, M3, Muscarinic Receptors, Muscarinic M3 Receptor, Muscarinic M3 Receptors, Receptor M3, Muscarinic, Receptors M3, Muscarinic
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
recessive Describing an allele whose effect with respect to a particular trait is not evident in heterozygotes. Opposite to dominant.
Ãâó: www.fao.org/docrep/003/X3910E/X3910E21.htm
recombinant A term used in both classical and molecular genetics.
Ãâó: www.fao.org/docrep/003/X3910E/X3910E21.htm
reconstructive surgery surgery to rebuild part of the body that has been damaged or defective from birth
Ãâó: www.american-depot.com/services/resources_gl_r.asp
rectum a short tube located at the end of the large intestine, which connects the intestine to the anus
Ãâó: www.american-depot.com/services/resources_gl_r.asp
rectal prolapse bulging of the lining of the rectum through the anus, usually due to straining during a bowel movement
Ãâó: www.american-depot.com/services/resources_gl_r.asp
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • reckoning
    °è»ê¼­
  • reckoning
    °è»ê(calculation);û»ê;°è»ê¼­(¼úÁý µîÀÇ)ÀÀº¸;¹ú;(õ¹® °üÃø¿¡ÀÇÇÑ)¹è À§Ä¡ÀÇ Ãß»ê(»êÁ¤)
  • reclaim
    °³½É½ÃŰ´Ù
  • reclaim
    ±³Á¤(°³¼±)ÇÏ´Ù(reform);°³½É½ÃŰ´Ù;°³°£ÇÏ´Ù;(¶¥À»)¸Þ¿ì´Ù;°£Ã´ÇÏ´Ù;(¹Ì°³ÀÎÀ»)°³È­(±³È­)ÇÏ´Ù(civilize);(ÀÚ¿øÀ»)ÀÌ¿ëÇÏ´Ù;Àç»ýÀÌ¿ëÇÏ´Ù;±³Á¤;±³È­;°³°£;°³Ã´;¸Å¸³;(Æó¹°ÀÇ)Àç»ý;ÀÌ¿ë;Àç»ý°í¹«;~able;~er
  • reclaimant
    °³°£ÀÚ;±³Á¤ÀÚ
  • reclamation
    °³½É
  • reclamation
    ±³Á¤;°³°£;°£Ã´;¸ÅÃà;(µ¿¹°ÀÇ)±æµéÀÓ;(¹Ì°³ÀÎÀÇ)±³È­
  • reclassify
    ´Ù½Ã ºÐ·ùÇÏ´Ù;(Á¤º¸ÀÇ)±â¹Ð ºÐ·ù¸¦ ¹Ù²Ù´Ù
  • reclinate
    ¹ØÀ¸·Î ±ÁÀº
  • recline
    ±â´ë°Ô ÇÏ´Ù
  • recline
    ±â´ë°ÔÇÏ´Ù;´¯È÷´Ù;±â´ë´Ù(lean);´¯´Ù;ÀÇÁöÇÏ´Ù
  • recliner
    ±â´ë´Â »ç¶÷(°Í);=RECLINING CHAIR
  • reclining chair
    ¾È¶ôÀÇÀÚ(µî°ú ¹ß¹ÞħÀ» ¾ÕµÚ·Î Á¶ÀýÇÒ ¼ö ÀÖÀ½)
  • reclosable
    (Æ÷Àå ¿ë±â µî)´Ù½Ã ¹ÐÆó½Ãų ¼ö ÀÖ´Â
  • reclothe
    ´Ù½Ã ¿ÊÀ» ÀÔÈ÷´Ù;»õ·Î ÀÔÈ÷´Ù;°¥¾Æ ÀÔÈ÷´Ù
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 12
REC of genes
REC gene that produces its characteristic phenotype only when its allele is identical
REC charge anew
REC load anew with ammunition, "She reloaded the gun carefully"
REC capable of being recharged
REC warmed leftovers
REC lavishly elegant and refined
REC food of a ruminant regurgitated to be chewed again
REC go back to bad behavior
REC habitual relapse into crime
REC someone who lapses into previous undesirable patterns of behavior
REC someone who is repeatedly arrested for criminal behavior (especially for the same criminal behavior)
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 12
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á